Lexaria Bioscience (LEXX) Other Non Operating Income (2022 - 2025)
Historic Other Non Operating Income for Lexaria Bioscience (LEXX) over the last 6 years, with Q4 2025 value amounting to -$22080.0.
- Lexaria Bioscience's Other Non Operating Income fell 3868.48% to -$22080.0 in Q4 2025 from the same period last year, while for Nov 2025 it was -$62901.0, marking a year-over-year decrease of 14619.75%. This contributed to the annual value of -$30697.0 for FY2025, which is 4471.4% up from last year.
- As of Q4 2025, Lexaria Bioscience's Other Non Operating Income stood at -$22080.0, which was down 3868.48% from -$15921.0 recorded in Q4 2024.
- Lexaria Bioscience's Other Non Operating Income's 5-year high stood at $17299.0 during Q2 2023, with a 5-year trough of -$134902.0 in Q3 2023.
- For the 4-year period, Lexaria Bioscience's Other Non Operating Income averaged around -$27202.8, with its median value being -$19000.5 (2024).
- Examining YoY changes over the last 5 years, Lexaria Bioscience's Other Non Operating Income showed a top increase of 11222.59% in 2024 and a maximum decrease of 33927.97% in 2024.
- Over the past 4 years, Lexaria Bioscience's Other Non Operating Income (Quarter) stood at -$73887.0 in 2022, then skyrocketed by 37.88% to -$45896.0 in 2023, then surged by 65.31% to -$15921.0 in 2024, then plummeted by 38.68% to -$22080.0 in 2025.
- Its Other Non Operating Income was -$22080.0 in Q4 2025, compared to -$15921.0 in Q4 2024 and $16493.0 in Q3 2024.